Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

2.

'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.

Bloor M, McIntosh J, McKeganey N, Robertson M.

Public Health. 2008 Oct;122(10):1013-9. doi: 10.1016/j.puhe.2008.01.007. Epub 2008 May 19.

PMID:
18490036
3.

The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence.

Williamson A, Darke S, Ross J, Teesson M.

Drug Alcohol Depend. 2006 Feb 28;81(3):293-300. Epub 2005 Sep 9.

PMID:
16154714
4.

Characteristics of heroin and cocaine users unknown to treatment agencies. Results from the Swiss Hidden Population Study.

Hausser D, K├╝bler D, Dubois-Arber F.

Soz Praventivmed. 1999;44(5):222-32.

PMID:
10588038
6.

Recent life problems and non-fatal overdose among heroin users entering treatment.

Neale J, Robertson M.

Addiction. 2005 Feb;100(2):168-75.

PMID:
15679746
7.

One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).

Teesson M, Ross J, Darke S, Lynskey M, Ali R, Ritter A, Cooke R.

Drug Alcohol Depend. 2006 Jun 28;83(2):174-80. Epub 2005 Dec 15.

PMID:
16343809
8.
9.
10.

Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.

Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI.

Health Technol Assess. 2005 Nov;9(42):1-174. Review.

11.

Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.

Ngo HT, Tait RJ, Hulse GK.

Arch Gen Psychiatry. 2008 Apr;65(4):457-65. doi: 10.1001/archpsyc.65.4.457.

PMID:
18391134
12.

Patterns of major depression and drug-related problems amongst heroin users across 36 months.

Darke S, Mills K, Teesson M, Ross J, Williamson A, Havard A.

Psychiatry Res. 2009 Mar 31;166(1):7-14. doi: 10.1016/j.psychres.2007.12.007. Epub 2009 Feb 11.

PMID:
19215987
13.

The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).

Teesson M, Mills K, Ross J, Darke S, Williamson A, Havard A.

Addiction. 2008 Jan;103(1):80-8. Epub 2007 Nov 8.

PMID:
17995994
14.

Young people with heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).

Mills KL, Teesson M, Darke S, Ross J, Lynskey M.

J Subst Abuse Treat. 2004 Jul;27(1):67-73.

PMID:
15223096
15.

The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence.

Darke S, Ross J, Williamson A, Teesson M.

Addiction. 2005 Aug;100(8):1121-30.

PMID:
16042642
16.

The Andalusian trial on heroin-assisted treatment: a 2 year follow-up.

Oviedo-Joekes E, March JC, Romero M, Perea-Milla E.

Drug Alcohol Rev. 2010 Jan;29(1):75-80. doi: 10.1111/j.1465-3362.2009.00100.x.

PMID:
20078686
17.

Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian Treatment Outcome Study.

Darke S, Williamson A, Ross J, Teesson M.

Drug Alcohol Depend. 2006 Sep 15;84(2):201-5. Epub 2006 Apr 3.

PMID:
16580792
18.

Residential rehabilitation for drug users: a review of 13 months' intake to a therapeutic community.

Keen J, Oliver P, Rowse G, Mathers N.

Fam Pract. 2001 Oct;18(5):545-8.

PMID:
11604381
19.

The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).

Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, Cooke R.

Drug Alcohol Rev. 2005 Sep;24(5):411-8.

PMID:
16298835
20.

Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence.

Darke S, Hetherington K, Ross J, Lynskey M, Teesson M.

Drug Alcohol Rev. 2004 Jun;23(2):177-83.

PMID:
15370024

Supplemental Content

Support Center